These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets. Kim S, Ko JW, Kim JR. Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691 [Abstract] [Full Text] [Related]
48. Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Kim K, Sussman G, Hébert J, Lumry W, Lutsky B, Gates D. Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081 [Abstract] [Full Text] [Related]
49. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis]. Jia MH, Chen XY, Zhang Y, Liao ZS. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar 05; 31(5):369-373. PubMed ID: 29871264 [Abstract] [Full Text] [Related]
51. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA. Ann Allergy Asthma Immunol; 2003 May 05; 90(5):536-42. PubMed ID: 12775135 [Abstract] [Full Text] [Related]
54. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Pediatr Allergy Immunol; 2005 May 05; 16(3):267-75. PubMed ID: 15853959 [Abstract] [Full Text] [Related]
57. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis. Prenner BM, Lu S, Danzig MR. Allergy Asthma Proc; 2010 May 05; 31(6):493-8. PubMed ID: 21708061 [Abstract] [Full Text] [Related]